Literature DB >> 6383662

Determination of lysozyme in serum, urine, cerebrospinal fluid and feces by enzyme immunoassay.

J Brouwer, T van Leeuwen-Herberts, M Otting-van de Ruit.   

Abstract

Conjugates of human lysozyme and horseradish peroxidase (HRP) were prepared by means of the heterobifunctional reagent N-succinimidyl 3-(2-pyridyldithio) propionate. A conjugate containing 2 mol HRP/mol lysozyme was isolated by gel filtration and used as a labeled antigen in competitive enzyme immunoassays, in which anti-lysozyme rabbit IgG had been bound to wells of microtiter plates. The assay can detect as little as 1 microgram lysozyme/l. The following reference intervals have been established: 950-2450 micrograms/l for serum, 1.7-123 micrograms/l for urine, 17.6-118 micrograms/l for cerebrospinal fluid and 0.04-1.5 microgram/g for feces.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6383662     DOI: 10.1016/0009-8981(84)90097-4

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  13 in total

Review 1.  Lysozymes in the animal kingdom.

Authors:  Lien Callewaert; Chris W Michiels
Journal:  J Biosci       Date:  2010-03       Impact factor: 1.826

2.  Chitosan-based nanoparticles as a sustained protein release carrier for tissue engineering applications.

Authors:  Yaping Hou; Junli Hu; Hyejin Park; Min Lee
Journal:  J Biomed Mater Res A       Date:  2012-01-24       Impact factor: 4.396

3.  Development of chitosan-tripolyphosphate non-woven fibrous scaffolds for tissue engineering application.

Authors:  Falguni Pati; Basudam Adhikari; Santanu Dhara
Journal:  J Mater Sci Mater Med       Date:  2012-02-07       Impact factor: 3.896

4.  Marked increase of methylumbelliferyl-tetra-N-acetylchitotetraoside hydrolase activity in plasma from Gaucher disease patients.

Authors:  W R den Tandt; F van Hoof
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

5.  In vitro degradation and drug release of a biodegradable tissue adhesive based on functionalized 1,2-ethylene glycol bis(dilactic acid) and chitosan.

Authors:  Claudia Lurtz; Karsten Voss; Veronika Hahn; Frieder Schauer; Juergen Wegmann; Erich K Odermatt; Klaus-Peter Schmitz; Katrin Sternberg
Journal:  J Mater Sci Mater Med       Date:  2012-12-30       Impact factor: 3.896

6.  Clinical relapse in systemic lupus erythematosus: correlation with antecedent elevation of urinary free light-chain immunoglobulin.

Authors:  J E Hopper; W Sequeira; J Martellotto; E Papagiannes; L Perna; J L Skosey
Journal:  J Clin Immunol       Date:  1989-07       Impact factor: 8.317

7.  Fecal lysozyme in assessment of disease activity in inflammatory bowel disease.

Authors:  A van der Sluys Veer; J Brouwer; I Biemond; G E Bohbouth; H W Verspaget; C B Lamers
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

8.  The lysozyme-induced peptidoglycan N-acetylglucosamine deacetylase PgdA (EF1843) is required for Enterococcus faecalis virulence.

Authors:  Abdellah Benachour; Rabia Ladjouzi; André Le Jeune; Laurent Hébert; Simon Thorpe; Pascal Courtin; Marie-Pierre Chapot-Chartier; Tomasz K Prajsnar; Simon J Foster; Stéphane Mesnage
Journal:  J Bacteriol       Date:  2012-09-07       Impact factor: 3.490

9.  Multifunctional chitosan-magnetic graphene quantum dot nanocomposites for the release of therapeutics from detachable and non-detachable biodegradable microneedle arrays.

Authors:  Richard Justin; Biqiong Chen
Journal:  Interface Focus       Date:  2018-04-20       Impact factor: 3.906

10.  Chitosan as a Biomaterial: Influence of Degree of Deacetylation on Its Physiochemical, Material and Biological Properties.

Authors:  Leslie John Ray Foster; Sonia Ho; James Hook; Monica Basuki; Helder Marçal
Journal:  PLoS One       Date:  2015-08-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.